Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2

Isobel Routledge; Saki Takahashi; Adrienne Epstein; Jill Hakim; Owen Janson; Keirstinne Turcios; Jo Vinden; John Tomas Risos; Margaret Rose Baniqued; Lori Pham; Clara Di Germanio; Michael Busch; Margot Kushel; Bryan Greenhouse; Isabel Rodríguez-Barraquer

doi:10.1038/s41467-022-30051-x

Nature Communications (May 2022)

Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2

Isobel Routledge,
Saki Takahashi,
Adrienne Epstein,
Jill Hakim,
Owen Janson,
Keirstinne Turcios,
Jo Vinden,
John Tomas Risos,
Margaret Rose Baniqued,
Lori Pham,
Clara Di Germanio,
Michael Busch,
Margot Kushel,
Bryan Greenhouse,
Isabel Rodríguez-Barraquer

Affiliations

Isobel Routledge: Department of Medicine, University of California San Francisco
Saki Takahashi: Department of Medicine, University of California San Francisco
Adrienne Epstein: Department of Medicine, University of California San Francisco
Jill Hakim: Department of Medicine, University of California San Francisco
Owen Janson: Department of Medicine, University of California San Francisco
Keirstinne Turcios: Department of Medicine, University of California San Francisco
Jo Vinden: Department of Medicine, University of California San Francisco
John Tomas Risos: Department of Laboratory Medicine, University of California San Francisco
Margaret Rose Baniqued: Department of Laboratory Medicine, University of California San Francisco
Lori Pham: Department of Laboratory Medicine, University of California San Francisco
Clara Di Germanio: Vitalant Research Institute
Michael Busch: Department of Laboratory Medicine, University of California San Francisco
Margot Kushel: Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco
Bryan Greenhouse: Department of Medicine, University of California San Francisco
Isabel Rodríguez-Barraquer: Department of Medicine, University of California San Francisco

DOI: https://doi.org/10.1038/s41467-022-30051-x
Journal volume & issue: Vol. 13, no. 1
pp. 1 – 7

Abstract

Read online

Continued monitoring of SARS-CoV-2 at the population level is important for identifying at-risk groups. Here the authors analyse data from a serological surveillance platform in San Francisco and find considerable variation in infection and vaccination history by race/ethnicity and socioeconomic status.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal